Regadenoson
Back to searchMolecule Structure
Scientific Name
Regadenoson
Description of the Drug
Regadenoson is a coronary vasodilator used in radionuclide myocardial perfusion imaging (MPI).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06213
http://www.drugbank.ca/drugs/DB06213
Brand Name(s)
Lexiscan
Company Owner(s)
Hong Kong King Friend Industrial Co Ltd, Apotex Inc, Hospira Inc, Gland Pharma Ltd, Astellas Pharma Us Inc, International Medication Systems Ltd, Accord Healthcare Inc, Dr Reddys Laboratories Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Adenosine A2a receptor | SINGLE PROTEIN | AGONIST | CHEMBL251 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL678893 | |
PharmGKB | PA166129536 | |
DrugBank | DB06213 | |
PubChem: Thomson Pharma | 14854126 | 14927662 |
PubChem | 219024 | |
Nikkaji | J1.806.399I | |
BindingDB | 50119132 | |
EPA CompTox Dashboard | DTXSID4057712 | |
DrugCentral | 2362 | |
ChemicalBook | CB0501002 | |
Guide to Pharmacology | 5596 | |
rxnorm | REGADENOSON | REGADENOSON ANHYDROUS |
PubChem: Drugs of the Future | 12015422 | |
ChEBI | 135613 | |
ZINC | ZINC000013818943 |